US2012164660A1PendingUtilityA1
Method for using a diagnostic agent which includes a calcium binding protein assay reagent and assay method for calcium binding protein
Est. expiryMar 6, 2015(expired)· nominal 20-yr term from priority
C07K 14/4728C07K 16/18
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A bovine- or human-derived calcium-binding protein with a prescribed amino acid sequence, a method for its production, and antibodies against the protein and uses thereof.
Claims
exact text as granted — not AI-modified1 - 23 . (canceled)
24 . An assay method for calcium-binding protein, characterized by using a reagent comprising a monoclonal antibody specific to a calcium-binding protein comprising an amino acid sequence shown in SEQ ID NO: 19 or encoded by a nucleic acid sequence shown in SEQ ID NO: 1.
25 - 26 . (canceled)
27 . A method of using a diagnostic agent for diagnosing inflammatory diseases, neoplastic diseases, dermatosis or blood diseases of PMN (polymorphonuclear leukocytes), macrophages and these lineages, comprising the steps of forming a calcium binding protein assay reagent composed of a monoclonal antibody specific to a calcium-binding protein comprising an amino acid sequence shown in SEQ ID NO: 19 or encoded by a nucleic acid sequence shown in SEQ ID NO: 1 and using said calcium-binding protein assay reagent to diagnose the presence of such diseases.Join the waitlist — get patent alerts
Track US2012164660A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.